Target intelligence / Profile preview

CCNO divergent transcript (CCNO-DT)

Target
CCNO-DT
Molecular classification
Other (long non-coding RNA / lncRNA)
01

Overview

CCNO divergent transcript (CCNO-DT) is a long non-coding RNA (lncRNA) gene, not a classical therapeutic target such as a receptor, enzyme, transporter, or transcription factor. There is no evidence suggesting it directly encodes a protein or possesses classical druggability features. It is annotated at the CCNO locus. Divergent transcripts are commonly transcribed from promoters in the direction opposite to the coding gene, typically lacking protein-coding potential but sometimes involved in transcriptional regulation. Such ncRNAs can influence gene expression, chromatin architecture, or transcriptional directionality, though specific functional data for CCNO-DT are lacking. There is currently no evidence that CCNO-DT encodes a protein, directly acts as a disease gene, or is used as a therapeutic target. CCNO-DT should not be confused with CCNO (Cyclin O), which encodes a protein involved in cell cycle regulation. It is a divergent transcript defined by its genomic location relative to the CCNO gene, with no established drug interactions, mechanism of action, or established role in disease. If more specific or tissue/disease-related information becomes available regarding CCNO-DT, those details would refine this profile; currently, it is best classified as a long non-coding RNA with unclear biological and therapeutic significance.

Other names
CCNO-DTCCNO divergent transcript
02

Mechanism of action

Not applicable; no reported mechanism as a drug target

03

Biological functions

May be involved in gene expression regulation and chromatin organization, consistent with roles described for many divergent non-coding transcripts
04

Disease associations

No direct disease association or role as a biomarker has been established; may have theoretical relevance in diseases via gene regulation, but this is speculative

Beyond the preview

Go deeper on CCNO divergent transcript (CCNO-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CCNO divergent transcript (CCNO-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call